指南与共识眼底病与葡萄膜炎

亚洲国家糖尿病视网膜病变筛查指南的可用性与差异性

Availability and variability in guidelines on diabetic retinopathy screening in Asian countries.
指南 / 共识 · Br J Ophthalmol · 2017-03-14

该研究系统检索并联系亚洲50个国家的相关机构,比较各国糖尿病视网膜病变(DR)筛查指南与国际眼科理事会(ICO)指南的符合程度。结果显示仅11个亚洲国家发布了相关指南,覆盖不到亚洲一半人口,DR患病率中位数30.5%,但威胁视力的DR(STDR)率持续偏高,仅2/11指南完全符合ICO转诊标准。

要点

  • 亚洲仅11国发布DR筛查指南,覆盖不足亚洲一半人口。
  • 糖尿病患者中DR患病率中位数30.5%(IQR 23.2%-36.8%),与美英相似。
  • 11国指南均符合ICO筛查起始与复查标准,仅2国完全符合转诊标准。

核心结论

  • 亚洲国家需建立更全面、循证的DR筛查指南,以支持有效筛查项目实施,减少DR相关盲、改善患者结局并降低医疗成本。

研究设计与样本

  • 系统检索美国国家指南交换中心(National Guideline Clearinghouse)等数据库,并联系亚洲全部50个国家的当地糖尿病与眼科学会,获取已发表的DR筛查指南。

主要发现

  • 亚洲11个国家发布了相关指南,其中9个为一般糖尿病照护指南、2个为DR专项指南,覆盖不到亚洲一半人口。
  • 糖尿病患者中DR患病率中位数30.5%(IQR 23.2%-36.8%),与美国和英国相似;但STDR率持续偏高。
  • 11国指南均符合ICO关于筛查起始与复查时间的标准,但孕妇筛查间隔除外。
  • 11个指南中仅2个符合ICO转诊标准,6个部分符合。
  • 关于筛查流程、设备和人员的建议中,三分之一缺失或不完整。

关键数值与推荐

  • 糖尿病患者中DR患病率中位数30.5%(IQR 23.2%-36.8%)。
  • 11个指南中2个完全符合ICO转诊标准,6个部分符合;筛查起始与复查标准全部符合,孕妇筛查间隔除外。
  • 筛查流程、设备和人员建议中三分之一缺失或不完整。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetic retinopathy (DR) is a blinding yet treatable complication of diabetes. DR screening is highly cost-effective at reducing blindness. Amidst the rapidly growing diabetic population in Asia, the prevalence of DR in the region is relatively less well known. AIMS: To review existing national DR screening guidelines of 50 countries in Asia, compare them against the International Council of Ophthalmology (ICO) guideline, and summarise the prevalence rates of DR and sight-threatening DR (STDR) in these countries. METHODS: We systematically searched for published guidelines from the National Guideline Clearinghouse and other databases, and contacted local diabetic and ophthalmological associations of all 50 Asian countries. RESULTS: Eleven Asian countries have published relevant guidelines, nine of which pertain to general diabetes care and two are DR-specific, covering less than half of Asia's population. The median DR prevalence among patients with diabetes is 30.5% (IQR: 23.2%-36.8%), similar to the USA and the UK. However, rates of STDR are consistently higher. All guidelines from the 11 Asian countries fulfil the ICO standard on when to start and repeat screening, except for screening interval for pregnant patients. However, only 2 of the 11 guidelines fulfil the ICO referral criteria and 6 partially fulfil. A third of the recommendations on screening process, equipment and personnel is either unavailable or incomplete. CONCLUSIONS: Countries in Asia need to establish more comprehensive and evidence-based DR screening guidelines to facilitate the execution of robust screening programmes that could help reduce DR-related blindness, improve patient outcomes and reduce healthcare costs.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Wang LZ, Cheung CY, Tapp RJ, et al. Availability and variability in guidelines on diabetic retinopathy screening in Asian countries. Br J Ophthalmol. 2017. PMID: 28292772. doi:10.1136/bjophthalmol-2016-310002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。